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Abstract
The aim of this work is to investigate the optimal vaccine sharing between two SIR centers in the
presence of migration fluxes of susceptibles and infected individuals during the mumps outbreak. Opti-
mality of the vaccine allocation means the minimization of the total number of lost working days during
the whole period of epidemic outbreak [0, tf ], which can be described by the functional Q =
∫ tf
0
I(t)dt
where I(t) stands for the number of infectives at time t. We explain the behavior of the optimal allocation,
which depends on the model parameters and the amount of vaccine available V .
Keywords: epidemic models, mumps, SIR, optimal vaccination, vaccine allocation.
1 Introduction
Epidemics are one of the most destructive and dangerous phenomena for humanity. There have been
numerous historical confirmations of terrible pandemics that devastated vast territories and destroyed mil-
lions of people. Such epidemics are also possible now. With the development of mathematical models, such
as the Kermack-McKendrick or SIR model (see, e.g., [1, 2, 3]), it has become possible to predict spread of
epidemics over time (number of susceptible, invectives and immunized).
In this paper we consider the epidemics of mumps and optimal vaccine allocation for it. Mumps is a
viral disease caused by the mumps virus. Currently many countries are experiencing mumps outbreak. For
example, one of the largest mumps outbreaks in the United States was in 2006. Occurring in January, state
Iowa, the virus had quickly spread through 40 states by April resulting in 2786 reported cases through-
out the country. In December of the same year the total number of cases had increased to 6584 with 85
hospitalizations and no deaths [30].
The aim of this work is to investigate an optimal vaccine allocation in two SIR centers connected by the
steady migration fluxes during the mumps epidemics. The problem of optimal vaccination has been actively
researched since 1970s (see pioneer works [5, 6] and more recent [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18,
19, 20]). Most of these works concentrate on an isolated center and abundance of vaccine that is enough
to cover a significant fraction of the population. Unlimited amount and a quadratic cost of vaccines were
considered in the case of n centers in [21].
Limited amount of vaccine and its optimal allocation were investigated for non-interacting centers in
deterministic [22] and stochastic [23] cases. Interacting centers without migration in deterministic and
stochastic cases were considered in [24]. The optimal vaccine allocation in different vaccination schedules
in two centers was studied in [25] for the typical fixed parameters values without analyzing the dependence
of the parameters domain-wide. Interacting centers in the form of epidemic percolation network were
considered in [26, 27]. In [22] authors maximize the total number of people that escape infection, in
papers [23, 24] they minimize the final quantity of removed and infectives, in paper [25] they minimize a
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mortality. These functionals are interesting from a healthcare point of view. Unlike previous articles, we
concentrate on minimizing the natural functional Q =
∫ tf
0
I(t)dt, where I(t) is the number of infectives
and tf is the final moment of epidemic: t ∈ [0, tf ]. Moreover, we explore the dependence of Q from the
parameters of the model. This functional is interesting both in healthcare and medical insurance since it
relates to the total number of lost working days for the entire period of epidemic. To make our model more
plausible, we added migration fluxes between centers.
The classical SIR model in case of n centers and minimization of functional Q is governed by the
following ODEs (see e.g. [4]):
dSi
dt
= − β
Ni
SiIi −
∑
j 6=i
kijSi +
∑
j 6=i
kjiSj −min(wiV, Si)δ(t− t∗)
dIi
dt
=
β
Ni
SiIi − αIi −
∑
j 6=i
lijIi(t) +
∑
j 6=i
ljiIj
dRi
dt
= αIi(t) + min(wiV, Si)δ(t− t∗)
Q(w1, w2, . . . , wn) =
n∑
i=1
∫ tf
0
Ii(t)dt→ min
(w1,w2,...,wn):w1+w2+...+wn=1
Si(0) = Si0, Ii(0) = Ii0, Ri(0) = Ri0
n∑
i=1
[Si(t) + Ii(t) +Ri(t)] =
n∑
i=1
Ni
V ≤
n∑
i=1
Si(0).
(1)
Here Si(t), Ii(t), Ri(t) are interpreted as numbers of susceptibles, infectives and removed in the ith center
respectively, V is amount of vaccine available, wi is the fraction of vaccine stock V allocated in the ith
center, t∗ is the vaccination time, α is the recovery rate, β is the infection rate, kij is the transportation rate
of susceptibles from center i to center j, lij is the transportation rate of infectives from center i to center
j, i, j = 1, . . . , n, δ(t − t∗) is Dirac’s delta function implying a unit impulsive increase in the number
of vaccinated individuals. Note that in classic SIR model the population remains constant. Therefore, we
abandon the removed group R, since it can be deduced from S and I .
Rather than prophylactic or proactive vaccination, we focus on reactive vaccination administered after
the initial disease outbreak. The common wisdom suggests an early allocation of all available resources just
after the beginning of epidemic outbreak, but logistics create an unavoidable delay. The optimal division of
this vaccine crucially depends on the population sizes and migration rates. We analyze these dependencies in
a simplified model, where after a vaccination at the moment t∗ susceptibles immediately transform into the
removed group. In numerical simulations we use odeint function from SciPy package in Python. However,
due to Dirac’s delta function in Section 2, we use explicit Euler method to derive the optimal vaccination
time t∗.
Our paper is organized as follows. In Section 2 we account for the vaccination delay and analyze
the dependence Q on the total amount of vaccine in an isolated SIR center. In Section 3 an optimization of
vaccine sharing between two interacting SIR centers is studied for the cases of two identical (Subsection 3.1)
and asymmetric (Subsection 3.2) SIR centers. Summary and an outlook for a further work is given in
Section 4.
2
2 An isolated center
The model of an isolated SIR center with vaccination at the moment t∗ takes the form:
dS
dt
= − β
N
SI −min(S, V )δ(t− t∗)
dI
dt
=
β
N
SI − αI
dR
dt
= αI + min(S, V )δ(t− t∗)
V ≤ S(0), S(t) + I(t) +R(t) = N
Q(t∗) =
∫ tf
0
I(t)dt→ min
t∗
(2)
The basic reproduction number is defined as R0 = βα and in case of mumps R0 = 4. Without loss of
generality we can set the initial number of removed R0 = 0 and let α = 1 and β = 4.
We restrict our consideration to the instantaneous vaccination, but similar analysis can be done for more
realistic vaccination schedules.
Firstly, we analyze the dependence ofQ on the vaccination time for fixed share of the vaccine v = VS(0) .
Results of the numerical integration of ODEs (2) plotted in Figure 1(left) show that the optimal time of
vaccination is t∗ = 0 and the increase rate of Q depends on the initial number of infectives. Further time is
measured in the number of iteration in the simulation.
Figure 1: Left: Functional Q(t∗) for different I(0), normalized to the maximum value of the functional. t∗
is the vaccination time. Parameters: R0 = 4, v = 0.4
Right: Functional Q(v) for different I(0), normalized to the maximum value of the functional. Parameters:
R0 = 4, t
∗ = 0.
The greater number of initially infectives I(0) is, the more critical is the effect of latency (see Figure 1
(left)). Thus, the optimal time of vaccination is the time of epidemic registration t∗ = 0.
Now we assume that the vaccination time is optimal t∗ = 0. It is interesting to consider the dependence
of the functional Q on the available vaccine stock. Dependence of the functional Q on the vaccine share
v ≡ VS(0) for different values I(0) is shown in Figure 1 (right). Note that the dependence is not linear and for
any parameters there exists a threshold v∗(I0) such that Q becomes sufficiently small and does not change
significantly for v ≥ v∗. The amount v∗ is essentially enough to suppress the epidemic as demonstrated in
Figure 1(right).
3 Two interacting SIR centers
In this section we study numerically the model described by equations (1) with vaccination time t∗ = 0
for the simplest network of two interacting SIR centers, and show how to allocate the available vaccine
optimally depending on the model parameters.
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The system of ODEs (1) in case of 2 centers has the following form:
dS1
dt
= − β1
N1
S1I1 − k12S1 + k21S2
dS2
dt
= − β2
N2
S2I2 − k21S2 + k12S1
dI1
dt
=
β1
N1
S1I1 − αI1 − l12I1 + l21I2
dI2
dt
=
β2
N2
S2I2 − αI2 − l21I2 + l12I1
dR1
dt
= αI1
dR2
dt
= αI2
Q(w1, w2) =
∫ tf
0
[I1(t) + I2(t)] dt→ min
(w1,w2):w1+w2=1
Sj(0) = Sj0 −min (Sj0, wjV )
Ij(0) = Ij0
Rj(0) = Rj0 + min (Sj0, wjV )
Sj0 + Ij0 +Rj0 = Nj , j = 1, 2
V ≤ S1(0) + S2(0),
2∑
j=1
[Sj(t) + Ij(t) +Rj(t)] = N1 +N2.
(3)
Clearly, the total number of vaccine is less than total number of susceptibles V ≤ S1(0) + S2(0). Further
we consider vaccine share and let v = VS1(0)+S2(0) , 0 ≤ v ≤ 1. For example, if v = 1 we can vaccinate all
population, if v = 0.5 - only half of susceptibles, etc.
Note that if the first center receives a vaccine share w1, then the second center receives the rest of the
fraction w2 = 1 − w1 even if the share of vaccine w2V is greater than the share of susceptibles in the
second center, which is not rational. Clearly, to minimize the functional Q(w1, 1− w1) ≡ Q(w1) we need
to use all of the vaccine volumes available. However, we will neglect these situations to simplify computer
calculations and also examine nonoptimal vaccine allocations.
3.1 Identical centers
Consider two identical SIR centers connected by symmetric migration fluxes and described by ODEs
(3). We are studying the dependence of epidemic spread on allocation of the vaccine in terms of the func-
tional Q for different v in [0.25, 0.70]. For a basic example consider the following parameters: N1 = N2 =
N = 1000, β1 = β2 = 4, α = 1, k12 = k21 = k = 0.01, l12 = l21 = l = 0.001, I1(0) = I2(0) = I = 10.
Results of the simulations for different fractions of the vaccine w1 are presented in Figure 2.
From Figure 2 we conclude that there are two thresholds v∗1 ≈ 0.36 and v∗2 ≈ 0.62. If v < v∗1 the
minimum value of functional Q(w1) is reached at the ends of the segment. For v > v∗2 he minimum value
of functional Q(w1) is reached at w1 = 0.5. Thus, if the vaccine share is small, we need to fully vaccinate
only one of the centers (by symmetry it does not matter which center we choose); for large volumes of
vaccine it is most reasonable to divide equally between the centers; otherwise, there is an optimal w1 6= 0.5
within a segment that minimizes Q(w1).
4
Figure 2: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.25, 0.4], normalized to the
maximum value of the functional. Parameters: R0 = 4, k = 0.01, l = 0.001, I = 0.01N .
Right: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.5, 0.7], normalized to the maximum value
of the functional. Parameters: R0 = 4, k = 0.01, l = 0.001, I = 0.01N .
Threshold v∗1 is the most interesting. With increase of the vaccine share w1 we abandon the previous
strategy and start to divide the vaccine according to Figure 2 (right). An existence of the threshold v∗1 may
be due to the existence of the similar threshold v∗ in the SIR model with one center. The additional vaccine
units in model with one center does not change the functional significantly. In the model with two identical
centers it means that if there is a sufficient level of vaccine in one center, an additional unit of vaccine is
much more valuable in another city. Eventually we divide vaccine equally between two centers.
Further, our goal is to study the dependence of the threshold on the parameters: v∗1 = v
∗
1(I, lij , kij)
1. Dependence on the initial number of infectives I1,2(0) = I
Dependence of the functional Q on I is shown in Figure 3, where the initial value of infectives in both
centers is 10 time higher than in the basic example (see Figure 2). In this case, the threshold decreases to
v∗1 ≈ 0.344. We need to divide the vaccine between two centers for v ≥ v∗1 . The large number of initial
infectives can be interpreted as vaccination delay. As we have seen in Figure 1 this delay significantly
reduces the effectiveness of vaccination.
Figure 3: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.25, 0.4], normalized to the
maximum value of the functional. Parameters: R0 = 4, k = 0.01, l = 0.001, I = 0.1N .
Right: Functional Q(w1, w2), w1 +w2 = 1 for different v ∈ [0.5, 0.65], normalized to the maximum value
of the functional. Parameters: R0 = 4, k = 0.01, l = 0.001, I = 0.1N .
2. Dependence on the migration activity of susceptibles
Let the migration activity of susceptibles kij increase 10 times in both centers. Then the threshold
increases to v∗1 ≈ 0.384. When v > v∗1 and the migration activity of healthy people is high, it becomes
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more efficient to allocate the vaccine in both centers (see Figure 4).
Figure 4: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.25, 0.4], normalized to the
maximum value of the functional. Parameters: R0 = 4, k = 0.1, l = 0.001, I = 0.01N .
Right: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.5, 0.7], normalized to the maximum value
of the functional. Parameters: R0 = 4, k = 0.1, l = 0.001, I = 0.01N .
3. Dependence on the migration activity of infectives
Let the migration activity of infectives increase 10 times in both centers. In this case v∗1 ≈ 0.358 (see
Figure 5 (left)). Note that the threshold v∗1 has decreased comparing to the basic example. Thus, in the case
of high mobility of the infectives it is more reasonable to divide the vaccine between both centers.
Figure 5: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.25, 0.4], normalized to the
maximum value of the functional. Parameters: R0 = 4, k = 0.01, l = 0.01, I = 0.01N .
Right: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.5, 0.7], normalized to the maximum value
of the functional. Parameters: R0 = 4, k = 0.01, l = 0.01, I = 0.01N .
3.2 Non-symmetric SIR centers
3.2.1 Source of the disease: different numbers of initial infectives Ii(0)
Now we study the dependence of the functional Q on different numbers of initial infectives (see Fig-
ure 6). A common sense suggests that the entire vaccine stock is to be concentrated in the center with the
greater number of infected. However, this intuition is misleading.
Surprisingly, we must allocate the most part of the vaccine in the center with the smaller number of
initial infectives. Center with the larger number of infectives may be interpreted as a similar center with
basic parameters at some time moment t > 0. As shown before, the optimal vaccination time is t∗ = 0, so
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it is more optimal to vaccinate the center with lower number of infectives. Eventually, having large amount
of vaccine we must allocate it equally between the two centers.
Figure 6: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.25, 0.4], normalized to the
maximum value of the functional. Parameters: R0 = 4, I1(0) = 0.01N, I2(0) = 0.1N .
Right: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.5, 0.7], normalized to the maximum value
of the functional. Parameters: R0 = 4, I1(0) = 0.01N, I2(0) = 0.1N .
3.2.2 Mass Migration: different mobility rates kij , lij
Let the rates k12 = 10k21 and l12 = 10l21 (i.e., the flow is directed from the first host center to the guest
center).
Surprisingly, the most efficient strategy is to vaccinate the host center in case of low vaccine stock
v ≤ v∗1 ≈ 0.318 (see Figure 7). Moreover, a new threshold v¯ ≈ 0.397 appears that correspond to a switch
of vaccination from the host to the guest center. Therefore, we allocate the vaccine in the host center for
v ≤ v∗1 , divide between two centers (prioritizing host center) for v∗1 < v < v¯, and divide between two
centers (prioritizing guest center) for v > v¯.
Figure 7: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.07, 0.4], normalized to the maxi-
mum value of the functional. Parameters: R0 = 4, k12 = 0.1, l12 = 0.01, k21 = 0.01, l21 = 0.001, I1(0) =
I2(0) = 0.01N .
Right: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.5, 0.7], normalized to the maximum value
of the functional. Parameters: R0 = 4, k12 = 0.1, l12 = 0.01, k21 = 0.01, l21 = 0.001, I1(0) = I2(0) =
0.01N .
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3.2.3 Big and Small: different number of populations
Let the second center have the larger population: N2 = 2N1, N1 = 1000 I1(0) = I2(0) = 0.005(N1 +
N2).
In case of small v we allocate all vaccine stock in the center with the smallest population (see Figure 8).
The threshold is approximately v∗1 ≈ 0.24.
Note that the full stock v = 1 allows vaccinating all susceptibles. Thus, at v = 1 the vaccine share
in smaller center is w1 ≈ 0.33, since we have S1(0) = 985, S2(0) = 1985, and we can vaccinate all
population. Therefore, w1 = S1S1+S2 ≈ 0.33.
Figure 8: Left: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.20, 0.40], normalized to the
maximum value of the functional. Parameters: R0 = 4, N2 = 2N1, k12 = 0.01, l12 = 0.001, k21 =
0.01, l21 = 0.001, I1(0) = 0.005(N1 +N2), I2(0) = 0.005(N1 +N2).
Right: Functional Q(w1, w2), w1 + w2 = 1 for different v ∈ [0.5, 1.0], normalized to the maximum
value of the functional. Parameters: R0 = 4, N2 = 2N1, k12 = 0.01, l12 = 0.001, k21 = 0.01, l21 =
0.001, I1(0) = 0.005(N1 +N2), I2(0) = 0.005(N1 +N2).
4 Conclusion
In this paper we analyze the importance of the optimal allocation of a vaccine stockpile in order to
minimize a natural functional Q, i.e., the number of lost working days for the whole period of epidemic
outbreak. The numerical simulations demonstrated that the optimal allocation of vaccine may reduce the
functional Q significantly. The effect of optimization is not negligible: in some cases Q decreases more
than 2 times from the initial value. For real life it is a fantastic result.
Further studies may be associated with the development of a model for the n centers and more precise
specification of interaction. More detailed model of migration fluxes taking into account the different dy-
namics of susceptibles and infected species was proposed in [28]. We expect more precise resemblance to
real life optimal vaccination in the model described in [28]. Quarantine, the latent period of the disease, risk
group population structure will make a model very close to reality.
Also, the comparison of deterministic model with the stochastic SIR model will provide an additional
insight of taking into account the nonzero probability that infection might fail to spread in a network of
interacting centers.
Another interesting subject of research is the choice of the functional specification, i.e., it can be selected
based on the price of the vaccine and economic losses related to the non-used amount of vaccine, etc.
In the future papers all these questions will be investigated and results will be compared with the real
data.
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